Search results
Pharmaceutical Giant Cencora Confirms Patient Data Breach Impacting over a Dozen Pharma Companies -...
CPO Magazine· 6 days agoU.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive...
Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 25,000 Shares of Collegium ... By...
Investing.com· 8 hours agoThe transaction was reported in a recent SEC Filing. Following this transaction, the insider now...
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 17 hours agoWill the recent negative trend continue leading up to its next earnings release, or is Rocket ...
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 10 hours agoOn June 3, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of...
Chinese Generic Ozempic, Wegovy Versions Could Put Novo Nordisk At The Risk Of Stiff Competition In...
Benzinga· 8 hours agoWhat Happened: As reported by Reuters on Sunday, at least 15 Chinese drugmakers are working on...
AstraZeneca completes acquisition of biopharma company Fusion Pharma
dpa international via Yahoo Finance· 1 day agoBritish pharmaceutical company AstraZeneca on Wednesday announced the completion of the acquisition...
2seventy bio executive sells shares worth over $2,700 By Investing.com
Investing.com· 10 hours agoIn a recent transaction on June 3rd, a senior executive at 2seventy bio, Inc. (NASDAQ:TSVT), a ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 1 hour agoPress release Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic Forum Qubit Pharmaceuticals joins the prestigious ...
Henan Lingrui Pharmaceutical Leads Three Key Dividend Stocks In China
Simply Wall St. via Yahoo Finance· 11 hours agoAs global markets grapple with mixed economic signals, China's equity landscape remains a focal...
Olema Pharmaceuticals director Cyrus Harmon sells shares worth over $250k By Investing.com
Investing.com· 1 day agoOlema Pharmaceuticals, Inc. (NASDAQ:OLMA) director Cyrus Harmon has sold a total of 25,000 shares of...
